Signature of Collapsars as Sources for High-energy Neutrinos and rr-process Nuclei

If collapsars are sources for both high-energy (HE) neutrinos and $r$-process nuclei, the profuse low-energy antineutrinos from $\beta$-decay of the newly-synthesized nuclei can annihilate the HE neutrinos. Considering HE neutrinos produced at internal shocks induced by intermittent mildly-magnetized jets, we show that such annihilation suppresses the overall HE neutrino spectrum at $\gtrsim 300$~TeV and produces a corresponding flavor composition of $(F_{\nu_e+\bar\nu_e}: F_{\nu_\mu+\bar\nu_\mu}: F_{\nu_\tau+\bar\nu_\tau})_\star \approx (1 : 10 : 1)$ at source. We find that the emergent HE neutrino flux can well fit the diffuse flux observed at IceCube if contributions from all similar sources are taken into account. Our results highlight the unique role of HE neutrinos in supporting collapsars as sources for $r$-process nuclei, and can be tested by accurate measurement of the diffuse HE neutrino flux spectrum and flavor composition, as well as detection of HE neutrinos from individual sources.Comment: 10 pages, 7 figure

Neutrinos and nucleosynthesis of elements

Neutrinos are known to play important roles in many astrophysical scenarios from the early period of the big bang to current stellar evolution being a unique messenger of the fusion reactions occurring in the center of our sun. In particular, neutrinos are crucial in determining the dynamics and the composition evolution in explosive events such as core-collapse supernovae and the merger of two neutron stars. In this paper, we review the current understanding of supernovae and binary neutron star mergers by focusing on the role of neutrinos therein. Several recent improvements on the theoretical modeling of neutrino interaction rates in nuclear matter as well as their impact on the heavy element nucleosynthesis in the supernova neutrino-driven wind are discussed, including the neutrino-nucleon opacity at the mean field level taking into account the relativistic kinematics of nucleons, the effect due to the nucleon-nucleon correlation, and the nucleon-nucleon bremsstrahlung. We also review the framework used to compute the neutrino-nucleus interactions and the up-to-date yield prediction for isotopes from neutrino nucleosynthesis occurring in the outer envelope of the supernova progenitor star during the explosion. Here improved predictions of energy spectra of supernova neutrinos of all flavors have had significant impact on the nucleosynthesis yields. Rapid progresses in modeling the flavor oscillations of neutrinos in these environments, including several novel mechanisms for collective neutrino oscillations and their potential impacts on various nucleosynthesis processes are summarized.Comment: Review paper submitted to PPN

R-process beta-decay neutrino flux from binary neutron star merger and collapsar

This study investigates the antineutrinos production by $\beta$-decay of $r$-process nuclei in two astrophysical sites that are capable of producing gamma-ray bursts (GRBs): binary neutron star mergers (BNSMs) and collapsars, which are promising sites for heavy element nucleosynthesis. We employ a simplified method to compute the $\beta$-decay $\bar\nu_e$ energy spectrum and consider two representative thermodynamic trajectories for $r$-process simulations, each with four sets of $Y_e$ distribution. The time evolution of the $\bar\nu_e$ spectrum is derived for both the dynamical ejecta and the disk wind for BNSMs and collapsar outflow, based on approximated mass outflow rates. Our results show that the $\bar\nu_e$ has an average energy of approximately 3 to 9~MeV, with a high energy tail of up to 20 MeV. The $\bar\nu_e$ flux evolution is primarily determined by the outflow duration, and can thus remain large for $\mathcal{O}(10)$~s and $\mathcal{O}(100)$~s for BNSMs and collapsars, respectively. For a single merger or collapsar at 40~Mpc, the $\bar\nu_e$ flux is $\mathcal{O}(10-100)$~cm$^{-2}$~s$^{-1}$, indicating a possible detection horizon up to $0.1-1$~Mpc for Hyper-kamiokande. We also estimate their contributions to the diffuse $\bar\nu_e$ background. Our results suggest that although the flux from BNSMs is roughly 4--5 orders of magnitude lower than that from the regular core-collapse supernovae, those from collapsars can possibly contribute a non-negligible fraction to the total diffuse $\bar\nu_e$ flux at energy $\lesssim 1$~MeV, with a large uncertainty depending on the unknown rate of collapsars capable of hosting the $r$-process.Comment: 13 pages, 7 figure

Design, Synthesis and Anti-HIV Integrase Evaluation of 4-Oxo-4H-quinolizine-3-carboxylic Acid Derivatives

4-Oxo-4H-quinolizine-3-carboxylic acid derivatives bearing sulfamido, carboxylamido, benzimidazole and benzothiazole substituents have been designed and synthesized. The structures of these new compounds were confirmed by 1H-NMR, 13C- NMR, IR and ESI (or HRMS) spectra. Compounds were screened for possible HIV integrase inhibitory activity

The LAMOST Survey of Background Quasars in the Vicinity of the Andromeda and Triangulum Galaxies -- II. Results from the Commissioning Observations and the Pilot Surveys

We present new quasars discovered in the vicinity of the Andromeda and Triangulum galaxies with the LAMOST during the 2010 and 2011 observational seasons. Quasar candidates are selected based on the available SDSS, KPNO 4 m telescope, XSTPS optical, and WISE near infrared photometric data. We present 509 new quasars discovered in a stripe of ~135 sq. deg from M31 to M33 along the Giant Stellar Stream in the 2011 pilot survey datasets, and also 17 new quasars discovered in an area of ~100 sq. deg that covers the central region and the southeastern halo of M31 in the 2010 commissioning datasets. These 526 new quasars have i magnitudes ranging from 15.5 to 20.0, redshifts from 0.1 to 3.2. They represent a significant increase of the number of identified quasars in the vicinity of M31 and M33. There are now 26, 62 and 139 known quasars in this region of the sky with i magnitudes brighter than 17.0, 17.5 and 18.0 respectively, of which 5, 20 and 75 are newly-discovered. These bright quasars provide an invaluable collection with which to probe the kinematics and chemistry of the ISM/IGM in the Local Group of galaxies. A total of 93 quasars are now known with locations within 2.5 deg of M31, of which 73 are newly discovered. Tens of quasars are now known to be located behind the Giant Stellar Stream, and hundreds behind the extended halo and its associated substructures of M31. The much enlarged sample of known quasars in the vicinity of M31 and M33 can potentially be utilized to construct a perfect astrometric reference frame to measure the minute PMs of M31 and M33, along with the PMs of substructures associated with the Local Group of galaxies. Those PMs are some of the most fundamental properties of the Local Group.Comment: 26 pages, 6 figures, AJ accepte

Proton-Boron Fusion Yield Increased by Orders of Magnitude with Foam Targets

A novel intense beam-driven scheme for high yield of the tri-alpha reaction 11B(p,{\alpha})2{\alpha} was investigated. We used a foam target made of cellulose triacetate (TAC, C_9H_{16}O_8) doped with boron. It was then heated volumetrically by soft X-ray radiation from a laser heated hohlraum and turned into a homogenous, and long living plasma. We employed a picosecond laser pulse to generate a high-intensity energetic proton beam via the well-known Target Normal Sheath Acceleration (TNSA) mechanism. We observed up to 10^{10}/sr {\alpha} particles per laser shot. This constitutes presently the highest yield value normalized to the laser energy on target. The measured fusion yield per proton exceeds the classical expectation of beam-target reactions by up to four orders of magnitude under high proton intensities. This enhancement is attributed to the strong electric fields and nonequilibrium thermonuclear fusion reactions as a result of the new method. Our approach shows opportunities to pursue ignition of aneutronic fusion

HCV 6a Prevalence in Guangdong Province Had the Origin from Vietnam and Recent Dissemination to Other Regions of China: Phylogeographic Analyses

Recently in China, HCV 6a infection has shown a fast increase among patients and blood donors, possibly due to IDU linked transmission.We recruited 210 drug users in Shanwei city, Guangdong province. Among them, HCV RNA was detected in 150 (71.4%), both E1 and NS5B genes were sequenced in 136, and 6a genotyped in 70. Of the 6a sequences, most were grouped into three clusters while 23% represent emerging strains. For coalescent analysis, additional 6a sequences were determined among 21 blood donors from Vietnam, 22 donors from 12 provinces of China, and 36 IDUs from Liuzhou City in Guangxi Province. Phylogeographic analyses indicated that Vietnam could be the origin of 6a in China. The Guangxi Province, which borders Vietnam, could be the first region to accept 6a for circulation. Migration from Yunnan, which also borders Vietnam, might be equally important, but it was only detected among IDUs in limited regions. From Guangxi, 6a could have further spread to Guangdong, Yunnan, Hainan, and Hubei provinces. However, evidence showed that only in Guangdong has 6a become a local epidemic, making Guangdong the second source region to disseminate 6a to the other 12 provinces. With a rate of 2.737×10⁻³ (95% CI: 1.792×10⁻³ to 3.745×10⁻³), a Bayesian Skyline Plot was portrayed. It revealed an exponential 6a growth during 1994-1998, while before and after 1994-1998 slow 6a growths were maintained. Concurrently, 1994-1998 corresponded to a period when contaminated blood transfusion was common, which caused many people being infected with HIV and HCV, until the Chinese government outlawed the use of paid blood donations in 1998.With an origin from Vietnam, 6a has become a local epidemic in Guangdong Province, where an increasing prevalence has subsequently led to 6a spread to many other regions of China

Clopidogrel Plus Aspirin vs Aspirin Alone in Patients With Acute Mild to Moderate Stroke

Importance Dual antiplatelet therapy has been demonstrated to be superior to single antiplatelet in reducing recurrent stroke among patients with transient ischemic attack or minor stroke, but robust evidence for its effect in patients with mild to moderate ischemic stroke is lacking. Objective To evaluate whether dual antiplatelet therapy is superior to single antiplatelet among patients with mild to moderate ischemic stroke. Design, Setting, and Participants This was a multicenter, open-label, blinded end point, randomized clinical trial conducted at 66 hospitals in China from December 20, 2016, through August 9, 2022. The date of final follow-up was October 30, 2022. The analysis was reported on March 12, 2023. Of 3065 patients with ischemic stroke, 3000 patients with acute mild to moderate stroke within 48 hours of symptom onset were enrolled, after excluding 65 patients who did not meet eligibility criteria or had no randomization outcome. Interventions Within 48 hours after symptom onset, patients were randomly assigned to receive clopidogrel plus aspirin (n = 1541) or aspirin alone (n = 1459) in a 1:1 ratio. Main Outcomes and Measures The primary end point was early neurologic deterioration at 7 days, defined as an increase of 2 or more points in National Institutes of Health Stroke Scale (NIHSS) score, but not as a result of cerebral hemorrhage, compared with baseline. The superiority of clopidogrel plus aspirin to aspirin alone was assessed based on a modified intention-to-treat population, which included all randomized participants with at least 1 efficacy evaluation regardless of treatment allocation. Bleeding events were safety end points. Results Of the 3000 randomized patients, 1942 (64.6%) were men, the mean (SD) age was 65.9 (10.6) years, median (IQR) NIHSS score at admission was 5 (4-6), and 1830 (61.0%) had a stroke of undetermined cause. A total of 2915 patients were included in the modified intention-to-treat analysis. Early neurologic deterioration occurred in 72 of 1502 (4.8%) in the dual antiplatelet therapy group vs 95 of 1413 (6.7%) in the aspirin alone group (risk difference −1.9%; 95% CI, −3.6 to −0.2; P = .03). Similar bleeding events were found between 2 groups. Conclusions and Relevance Among Chinese patients with acute mild to moderate ischemic stroke, clopidogrel plus aspirin was superior to aspirin alone with regard to reducing early neurologic deterioration at 7 days with similar safety profile. These findings indicate that dual antiplatelet therapy may be a superior choice to aspirin alone in treating patients with acute mild to moderate stroke.Trial RegistrationClinicalTrials.gov Identifier: NCT0286900

Design and baseline characteristics of the finerenone in reducing cardiovascular mortality and morbidity in diabetic kidney disease trial

Background: Among people with diabetes, those with kidney disease have exceptionally high rates of cardiovascular (CV) morbidity and mortality and progression of their underlying kidney disease. Finerenone is a novel, nonsteroidal, selective mineralocorticoid receptor antagonist that has shown to reduce albuminuria in type 2 diabetes (T2D) patients with chronic kidney disease (CKD) while revealing only a low risk of hyperkalemia. However, the effect of finerenone on CV and renal outcomes has not yet been investigated in long-term trials. Patients and Methods: The Finerenone in Reducing CV Mortality and Morbidity in Diabetic Kidney Disease (FIGARO-DKD) trial aims to assess the efficacy and safety of finerenone compared to placebo at reducing clinically important CV and renal outcomes in T2D patients with CKD. FIGARO-DKD is a randomized, double-blind, placebo-controlled, parallel-group, event-driven trial running in 47 countries with an expected duration of approximately 6 years. FIGARO-DKD randomized 7,437 patients with an estimated glomerular filtration rate >= 25 mL/min/1.73 m(2) and albuminuria (urinary albumin-to-creatinine ratio >= 30 to <= 5,000 mg/g). The study has at least 90% power to detect a 20% reduction in the risk of the primary outcome (overall two-sided significance level alpha = 0.05), the composite of time to first occurrence of CV death, nonfatal myocardial infarction, nonfatal stroke, or hospitalization for heart failure. Conclusions: FIGARO-DKD will determine whether an optimally treated cohort of T2D patients with CKD at high risk of CV and renal events will experience cardiorenal benefits with the addition of finerenone to their treatment regimen. Trial Registration: EudraCT number: 2015-000950-39; ClinicalTrials.gov identifier: NCT02545049